<\/p>\n
Kovid-19’un Eris varyant\u0131n\u0131n T\u00fcrkiye’de 9 ki\u015fide g\u00f6r\u00fclmesine ili\u015fkin AA muhabirine a\u00e7\u0131klamada bulunan Ankara \u00dcniversitesi T\u0131p Fak\u00fcltesi Enfeksiyon Hastal\u0131klar\u0131 Ana Bilim Dal\u0131 Ba\u015fkan\u0131 Prof. Dr. \u0130smail Bal\u0131k, Eris’in, Omicron’un bir alt varyant\u0131 oldu\u011funu belirterek, “Toplumsal a\u00e7\u0131dan tela\u015flanmam\u0131z\u0131 gerektirecek bir durum yok. Vir\u00fcsler s\u00fcrekli mutasyonlarla yeni varyantlar yaparlar ve toplumda hastal\u0131\u011f\u0131 enfeksiyonla devam ettirmeye \u00e7al\u0131\u015f\u0131rlar.” diye konu\u015ftu.<\/p>\n
Varyant hakk\u0131nda endi\u015fe edilmemesi gerekti\u011fini belirten Bal\u0131k, “Kovid-19 salg\u0131n\u0131, ilk g\u00f6r\u00fcld\u00fc\u011f\u00fc gibi hi\u00e7bir zaman olmayacak. Vir\u00fcs mutasyon ge\u00e7irse de art\u0131k d\u00fcnya toplumunun ba\u011f\u0131\u015f\u0131kl\u0131k sistemi, hastal\u0131\u011f\u0131 ge\u00e7irmekten ve a\u015f\u0131lanmaktan bu vir\u00fcs grubunu tan\u0131yor.” dedi.<\/p>\n
Bal\u0131k, Eris vakalar\u0131n\u0131n yurt d\u0131\u015f\u0131nda yakla\u015f\u0131k iki ay \u00f6nce art\u0131\u015f g\u00f6sterdi\u011fine de\u011finerek, bu varyant\u0131n T\u00fcrkiye’de de g\u00f6r\u00fclmesini do\u011fal kar\u015f\u0131lad\u0131\u011f\u0131n\u0131 dile getirdi.<\/p>\n
Prof. Dr. Bal\u0131k, Eris varyant\u0131n\u0131n belirtilerine ili\u015fkin, “\u00dcst solunum yolu enfeksiyonlar\u0131, bo\u011faz a\u011fr\u0131s\u0131, nezle, g\u00f6z ya\u015farmas\u0131, hap\u015f\u0131r\u0131k gibi belirtiler bulunuyor. Tat ve koku kayb\u0131 eskiye g\u00f6re az da olsa devam ediyor. Vakalarda ishal de g\u00f6r\u00fcl\u00fcyor.” bilgilerini verdi.<\/p>\n
Bu belirtileri g\u00f6steren ki\u015filerin hastaneye gitmesi halinde test yap\u0131ld\u0131ktan sonra net \u015fekilde tan\u0131 konulabilece\u011fini aktaran Bal\u0131k, belirtiler ge\u00e7ene kadar ki\u015filerin maske takmas\u0131n\u0131 gerekti\u011fini vurgulad\u0131.<\/p>\n
Vir\u00fcsten korunmak i\u00e7in hijyenin \u00f6nemini vurgulayan Bal\u0131k, ellerin s\u0131k s\u0131k y\u0131kanmas\u0131 gerekti\u011fini s\u00f6yledi.<\/p>\n
Bal\u0131k, “Daha \u00f6nce a\u015f\u0131 yapt\u0131ran sa\u011fl\u0131kl\u0131 bireylere yeniden a\u015f\u0131 yapt\u0131rmak konusunda D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc biraz rahat davran\u0131yor a\u00e7\u0131k\u00e7as\u0131. Biz ise \u00f6zellikle risk gruplar\u0131na \u00f6zenli davranmak gerekti\u011fini d\u00fc\u015f\u00fcn\u00fcyoruz. Son varyantlara kar\u015f\u0131 haz\u0131rlanm\u0131\u015f olan a\u015f\u0131 olursa a\u015f\u0131n\u0131n etkinli\u011fi de artar. \u0130lk varyanta kar\u015f\u0131 haz\u0131rlanm\u0131\u015f olan a\u015f\u0131n\u0131n etkinli\u011fi tabii ki daha az olacakt\u0131r. \u00d6n\u00fcm\u00fczdeki d\u00f6nemde yeni varyantlara kar\u015f\u0131 haz\u0131rlanm\u0131\u015f a\u015f\u0131lar piyasaya gelecektir.” diye konu\u015ftu.<\/p>\n
Belirtilerin ki\u015fiden ki\u015fiye de\u011fi\u015febildi\u011fini, hastalar\u0131n \u00e7o\u011funlukla k\u0131sa s\u00fcrede iyile\u015febildi\u011fini anlatan Bal\u0131k, \u015funlar\u0131 kaydetti:<\/p>\n
“Vir\u00fcs e\u011fer solunum yollar\u0131n\u0131 tutmu\u015fsa yani alt solunum yollar\u0131na, akci\u011fere inmi\u015fse hastal\u0131k s\u00fcresi 20-25 g\u00fcne kadar \u00e7\u0131kabiliyor. Sadece \u00fcst solunum yolunda s\u0131n\u0131rl\u0131 kalm\u0131\u015fsa 3-5 g\u00fcn i\u00e7inde, maksimum bir hafta i\u00e7inde \u00e7o\u011funlukla kendili\u011finden gidiyor. Dolay\u0131s\u0131yla ge\u00e7mi\u015ftekine g\u00f6re hafif seyretti\u011fini s\u00f6ylememiz gerekiyor.”<\/p>\n
Hastal\u0131\u011f\u0131n hafif semptomlarla seyretti\u011fi durumlarda hastay\u0131 izlediklerini ve grip, so\u011fuk alg\u0131nl\u0131\u011f\u0131 tedbirlerini uygulad\u0131klar\u0131n\u0131 s\u00f6yleyen Bal\u0131k, a\u011f\u0131r semptom g\u00f6sterenlere y\u00f6nelik ise \u00f6zel tedavi y\u00f6ntemlerinin bulundu\u011funu belirtti.<\/p>\n